Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Oncology | Hematology | Immunology

Lymphoproliferative disorders Clinical Trials

A listing of Lymphoproliferative disorders medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.

Filter by:

Phase:

Gender:

Age:

Location:

 

First 1 2 Last 

Alabama

Birmingham Alabama 35233

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

California

Orange California 92868

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

San Francisco California 94143

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

District of Columbia

Washington District of Columbia 20310

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Georgia

Atlanta Georgia 30307

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Illinois

Chicago Illinois 60637

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Chicago Illinois 60611

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Chicago Illinois 18150

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Indiana

Indianapolis Indiana 46202

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Massachusetts

Boston Massachusetts 02114

A clinical research study of bortezomib and rituximab for the treatment of Post-transplant Lymphoproliferative Disease, Solid Organ Transplant, Stem Cell Transplant (Bone Marrow Transplant) or Epstein Barr Virus Infections

Boston Massachusetts 02111

A Phase 1/Phase 2 clinical study for patients using brentuximab vedotin, rituximab and laboratory biomarker analysis

Michigan

Ann Arbor Michigan 48109

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Minnesota

Minneapolis Minnesota 55435

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Missouri

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

New York

New York New York 10032

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Ohio

Cincinnati Ohio 45229

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Cleveland Ohio 44106

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Oregon

Portland Oregon 97239

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Pennsylvania

Philadelphia Pennsylvania 19104

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Pittsburgh Pennsylvania 15224

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Tennessee

Memphis Tennessee 38105

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Texas

Houston Texas 77030

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Houston Texas 77030

Patients are needed to participate in a clinical research study of SGN-35

Washington

Seattle Washington 98105

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Wisconsin

Milwaukee Wisconsin 53226

Patients are needed to participate in a clinical research study evaluating anti-endosialin/TEM1 monoclonal antibody MORAb-004, pharmacological study and laboratory biomarker analysis

Czech Republic

UPDATED

Brno

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Prague

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

UPDATED

Praha Prague

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

UPDATED

Praha 10 Vinohrady

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

Usti nad Labem

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

France

Bordeaux

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Lille

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Lyon

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Toulouse

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Germany

Aachen

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Düsseldorf

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Tübingen

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Italy

Milano

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Pisa

A clinical research study of recMAGE-A3 + AS15 ASCI and Placebo for the treatment of Urinary Bladder Neoplasms

Japan

Chuo-ku Tokyo

A clinical trial seeking patients for a research study for the treatment of Peripheral T-Cell Lymphoma

Isehara Kanagawa

A clinical trial seeking patients for a research study for the treatment of Peripheral T-Cell Lymphoma

Kashiwa Chiba

A clinical trial seeking patients for a research study for the treatment of Peripheral T-Cell Lymphoma

Nagoya Aichi

A clinical trial seeking patients for a research study for the treatment of Peripheral T-Cell Lymphoma

NEW

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

View More ▼

NEW

Nagoya-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

NEW

Sendai-shi

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

NEW

Tokyo

Patients are needed to participate in a clinical research study evaluating ABT-199 for the treatment of Non-Hodgkin Lymphoma or Multiple Myeloma

Malaysia

UPDATED

Ampang Selangor

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

UPDATED

Kuala Lumpur

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

UPDATED

Penang

A clinical trial to evaluate treatments using Brentuximab vedotin for patients with Hodgkin Lymphoma

First 1 2 Last 

Receive E-mails About New Clinical Trials!

Sign up for our FREE service and we'll send you automatic email notifications as soon as a clinical trial is posted in the medical category you're interested in.